Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

This is to inform you that the Nomination & Remuneration Committee of Board of Directors of the Company has allotted on December 20, 2021 by way of resolution passed by circulation 6,03,575 Equity Shares of Rs.2/- each of the Company, fully paid up, at a price of Rs. 58.40/each (including premium of Rs. 56.40/-), to the eligible Employees on exercise of their Stock Options under Laurus Employees Stock Option Scheme, 2016. Further, the Nomination & Remuneration Committee of Board of Directors of the Company has allotted on December 20,2021 by way of resolution passed by circulation 1,53,375 Equity Shares of Rs.2/- each of the Company, fully paid up, at a price of Rs. 51.10/- each (including premium of Rs. 49.10/-), to the eligible Employees on exercise of their Stock Options under Laurus Employees Stock Option Scheme, 2018. The total paid up capital of the Company after the above allotments stands at Rs. 107,47, 18,670/-.
20-12-2021
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

This has reference to our disclosure dated November 19, 2021 regarding the signing of an investment agreement with M/s. Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company to acquire 26.62% stake (fully diluted basis), subject to completion of conditions precedent, for a cash consideration of approximately Rs. 46.00 Crores. In this regard, we wish to update that the Company has paid the subscription amount of Rs.27.60 Crores (Rupees Twenty-Seven Crores and Sixty Lakhs only) as 'Tranche 1 Subscription Amount' today (i.e. on December 09, 2021). Along with the Company, the senior management of the Company also paid the 'Tranche 1 Subscription Amount' today.
09-12-2021
Bigul

Laurus Labs Ltd - 540222 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NSN Holdings
02-12-2021

Buy Laurus Labs; target of Rs 690: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 690 in its research report dated November 21, 2021.
22-11-2021

Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore

Additionally, Laurus Labs' senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filing
20-11-2021
Bigul

Laurus Labs Ltd - 540222 - Disclosure Of Related Partv Transactions For The Half Vear Ended September 30,2021

In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, please find enclosed the details on Related Party Transactions for the half year ended September 30, 2021, on consolidated basis, prepared in accordance with applicable accounting standards.
19-11-2021
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Laurus Labs acquires substantial minority stake in a CAR-T cell therapy company - ImmunoACT.
19-11-2021
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Acquisition

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
19-11-2021
Bigul

Laurus Labs Ltd - 540222 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NSN Holdings
17-11-2021
Bigul

Laurus Labs Ltd - 540222 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Satyanarayana Chava
17-11-2021
Next Page
Close

Let's Open Free Demat Account